global potential analysis of ebola drug and vaccines market (pipeline analysis, drugs, vaccines, and...
DESCRIPTION
Market Research Reports, Inc. has announced the addition of “Global Potential Analysis of Ebola drug and Vaccines Market (Pipeline analysis, Drugs, Vaccines, and Geography) through 2020” research report to their offering. See more at- http://mrr.cm/ZzXTRANSCRIPT
www.MarketResearchReports.com
Global Potential Analysis of Ebola
drug and Vaccines Market (Pipeline analysis, Drugs, Vaccines, and Geography)
through 2020
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: September 14, 2014
Number of Pages: 55
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 2,625
Price For Site User License: USD 5,625
Price For Global User License: USD 8,625
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) of ebola virus.
Initial symptoms of this disease include sore throat, headaches, fever and muscles pain. It causes hemorrhagic fever that leads to internal or external bleeding. EVD is widely prevalent in Central and Western Africa, and near tropical rainforests
www.MarketResearchReports.com
Key Highlights
Global Potential Analysis of Ebola drug and Vaccines Market (Pipeline analysis, Drugs, Vaccines, and Geography) through 2020 anticipates that the Ebola Virus Disease (EVD) vaccines would gain a market value of $56 million by 2020.
Tekmira Pharmaceuticals, BioCryst Pharmaceutical Inc., Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceutical are some of the leading companies focusing on research activities to develop efficacious medicine for EVD.
Additionally, the governments in the developed countries have also taken formidable steps to support the research activities for the development of EVD therapeutics by providing funding and floating favorable policies.
www.MarketResearchReports.com
Key Highlights Continues…
In 2012, Sarepta Therapeutics had also received fast track designation for AVI-7537, a lead drug candidate for EVD. Both these companies are developing their anti-ebola products under the contract of the U.S. department of defense (DoD).
Ebola therapeutics and vaccines market is segmented on the basis of geography into North America, Europe, Asia-pacific and LAMEA. EVD is rampant in LAMEA regions, specifically in African countries. This is a positive sign for pharmaceutical companies, portraying a highly lucrative market in the future.
Earlier, US government did not have any regulations for EVD therapeutics due to negligible incidences of this disease in developed economies.
www.MarketResearchReports.com
Key Benefits:
To track commercial trends, major clinical trials and their status are pursued of closely
The report sheds light on the key events held in past years concerning the development of ebola viral disease therapeutics
Pin-point analysis of geographic segments helps to identify opportunities for growth within the ebola therapeutics and vaccines market
Porter’s Five Forces analysis examines the competitive structure of the ebola therapeutics and vaccines market and would assist market strategists in their respective decision making process
www.MarketResearchReports.com
Key Benefits Continues…
In-depth coverage of the ebola therapeutics and vaccines market including drivers, restraints and opportunities would help professionals to better understand market behavior
Detailed study of the strategies of key leaders, partnerships and acquisitions in the ebola therapeutics and vaccines market would be informative for professionals in corporate sector
www.MarketResearchReports.com
Report Coverage
1. Introduction2. Executive Summary3. Market Overview4. Forecaste Scenario Analysis Of Ebola Vaccines, 2013-
2020, ($Million)5. Global Pipeline And Market Potential Analysis Of E-
bola Therapeutic Vaccines Market By Geography, 2013 – 2020
6. Company Profiles
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Company Coverage
1. Tekmira Pharmaceuticals2. BioCryst Pharmaceutical Inc.3. Serepata Therapeutics4. NewLink Genetics Corp.5. Mapp Biopharmaceutical
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and purchase this publication:
http://mrr.cm/ZzX
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.
Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)